Sarah Butler is a Non-Executive Director of IAG and RACV’s Insurance Joint Venture IMA, Lumonus and Australian Clinical Labs Limited. She is also a Member of Chief Executive Women and Advisor of Sync Technologies.

Sarah is a former senior partner with Booz Allen and Strategy&, focused on health, insurance and government. She worked in 30+ countries including 5 years in China/Asia and also led PwC’s Global Health practice and NSW Government relationship through COVID-19.

Sarah joined the Board in November 2023 and is Chair of the People Committee and a Member of the Investment Committee.

Ms Sarah Coggan is a Senior Project Manager at the George Institute for Global Health (TGI) as well as for George Clinical, TGI’s commercial partner company. She has more than 15 years of experience working in clinical trials both in the academic and commercial settings.

Sarah has a science background in Pharmacology/ Communication and a Masters of Public Health. She began employment at the George Institute in July 2012 and has remained within the Renal Program, including 2 years based remotely in the United States. Her expertise lies in the implementation of pragmatic randomised clinical trials, data linkage, building collaborative relationships with commercial and academic Sponsors, and implementing corporate knowledge within future renal research activities.

Sarah is PhD student in the Injury Division at The George Institute. Her research interests surround the development and implementation of culturally competent and effective healthcare for Aboriginal and Torres Strait Islander children in tertiary health settings across Australia.

The majority of Sarah’s current research is focused on burn injury, specifically regarding the quality and cultural safety in burn injury models of care. Sarah is a registered nurse and also works closely with the Aboriginal community controlled health sector in South Australia.

Sarah Iqbal works at the George Institute as Research Manager in the India office and has 3+ years of experience in research administration. As a part of Research Support Services in CORE India, she assists researchers with pre-award funding processes. Sarah has a PhD in Biochemistry from Aligarh Muslim University where she spent 5+ years investigating the effect of vitamin D supplementation in diabetes and pancreatic cancer. She also worked briefly at the Institute of Genomics and Integrative Biology, New Delhi in the chemical genetics’ lab as a postdoctoral fellow, before joining DBT-Wellcome Trust India Alliance in the capacity of a Grants Adviser. At the George, Sarah also looks after the global publications database as the institutes Publications Officer. She is interested in developing her capacity in science policy research.

Dr Siddhardh Devarapalli works in Public Mental health at The George Institute for Global Health in India. He is trained in population studies with a Master’s Degree from the International Institute for Population Sciences (IIPS) in Mumbai. He also has an MPhil/PhD in Population Studies from Jawaharlal Nehru University. His previous work experience includes teaching Medical Humanities at the University of Hyderabad and conducting research in Health Systems at the Institute of Health Systems in Hyderabad, and on the Sociology of Health at the Dr B R Ambedkar Open University. At The George Institute Siddhardh has worked on mental health in rural and Scheduled Tribe areas which includes adolescent mental health in slums.

Dr. Shane Galgey MB BCh BAO NUI MRCP MRCS is an Irish trained physician in Gastroenterology, Hepatology, General Internal Medicine, with subspecialty training in HDU and Emergency Medicine.

He is currently works in Academic Project Operations in the divisions of Critical Care and Respiratory Medicine as a Project Manager/CRA. He also works as a Medical Monitor and provides Safety and Medical Advisory for Academic Project Operations Trials in TGI.

He is a keen researcher across TGI’s many therapeutic areas. He has an interest in Health Systems Research, Thought Leadership, Process Implementation Improvement, and Social Entrepreneurship. He recently has contributed to the Institute’s response to COVID-19 and is the Lead Investigator in a report exploring how to optimise clinical trials in the face of change to achieve maximum outputs.

Shane also holds a Conjoint Lecturer Position at UNSW School of Medicine.

Shani completed her bachelor’s in Medical Biotechnology and holds a Master’s degree in Public health from Amity University, India. In addition, Shani completed a course in Clinical Trial Fundamentals facilitated by Monash University, Australia and Project Management Fundamentals  by Australian Institute of Management.

Prior to joining George Institute, she worked as a Junior research fellow at the International Clinical Epidemiological Network (INCLEN) New Delhi on multiple epidemiological studies and was involved in project designing and database management. Presently, she is involved in the operations and management of academic randomised clinical trials like Long Covid ,PACE in COPD and works closely with the trial steering committees, regulatory authorities, ethics committees and clinical sites across India to conduct trials ethically and efficiently.

Sharon is a Senior Project Manager in Academic Project Operations at The George Institute for Global Health Australia. She is a Registered Nurse (Bachelor of Nursing) with clinical experience in general medicine and intensive care. In 2011, Sharon joined the Critical Care Program and has been involved in many academic-based studies; drawing on her previous experience as a Registered Nurse and an Intensive Care Research Coordinator to conduct clinical research that will benefit critically ill patients.

Sharon has extensive knowledge and experience in managing all aspects of multi-centre clinical trials, including protocol and case report form development, data management, ethics and regulatory requirements, investigational product, source data verification, data analysis, finance, risk management and people management. Whilst working in research for almost 20 years, Sharon has managed and coordinated projects in the following areas of critical care medicine: fluid resuscitation, COVID-19, blood glucose control, kidney failure, nutrition, severe trauma, traumatic brain injury, antibiotic use, temperature management and sepsis.

Sindhu is the Head of Data Management. Following completion of her Master’s degree in Clinical Data Management from the University of Sydney, she has fulfilled a variety of data and systems orientated roles across the research, hospital, pathology, medical device, biotechnology and health charity sectors.

Her expertise includes clinical data management, software implementation, project management, business analysis, gap analysis, process re-engineering, risk management, change management, systems validation, systems integration, privacy and data governance.

One of her key achievements at The George Institute has been leading the development and implementation of the SPoT database which has substantially improved the tracking and reporting of key Institute research activity such as funding, projects and publications.

Dr Sonali Gnanenthiran is a clinician-researcher (cardiologist), with experience spanning basic science to clinical trials. Her research interests include cardiovascular disease prevention, high blood pressure, high cholesterol, blood clotting, and cardiovascular ageing.

She graduated with Honours Class I from the University of NSW in Medicine and obtained fellowships from the Royal Australasian College of Physicians, and Cardiac Society of Australia and New Zealand. She completed her PhD at the University of Sydney, supported by a Heart Foundation/NHMRC scholarship. She is a cardiovascular researcher at the George Institute for Global Health, supported by the John Chalmers and Heart Foundation Fellowships. Additionally, she has honed her leadership in cardiovascular research through involvement in several trials (e.g., LOTUS, NEXTGEN-BP, Shop-to-Stop Hypertension, CO-OPERATE & PAX), which underscore her ability to drive impactful research. She is a member of the Australian Hypertension Taskforce Working Group, which aims to improve blood pressure control rates in Australia. 

Dr Gnanenthiran is a practising cardiologist at Concord Repatriation General Hospital and a senior lecturer at the University of NSW. She has more than 43 publications, 40 national/international conference presentations, and secured >$13.5 million in research funding including from top funding agencies (MRFF, Heart Foundation, NHMRC). Her key achievements include being awarded the 2023 American Heart Association [AHA] Karl Link Investigator Award for Thrombosis, 2023 CLIMB Research Scholars Award, 2020 & 2022 AHA Paul Dudley White International Scholar Awards, and the 2021 Scientific Medal of the Thrombosis and Haemostasis Society of Australia and New Zealand.

Sophia Zoungas is Professional Research Fellow at The George Institute and Head of Clinical Research and Diabetes Research Program  within the School of Public Health, Monash University.  She holds an National Heart Foundation CDA Fellowship and is a practising endocrinologist with clinical appointments at the RPAH Medical Centre, NSW and the Southern Health Care Network, Victoria.  Sophia’s research focuses on the management of Type 2 diabetes and its complications. Sophia is the international coordinator of the ADVANCE-ON study, a global long-term post-trial follow up study of the ADVANCE cohort that seeks to examine the legacy effects of intensive glucose control and routine blood pressure lowering in people with type 2 diabetes.

Srini Akkaraju, based in the US, is the Founder and Managing General Partner of Samsara BioCapital, a biotech investment firm. He is currently Director of vTv Therapeutics, Syros Pharmaceuticals, Mineralys Therapeutics, Scholar Rock and Alumis Inc.

Srini has served as a Director on many biotech boards. He was formerly a General Partner of Sonfinnova Venturers, Managing Director of New Leaf Venture Partners, Founding Managing Director at Panorama Capital and Partner with JP Morgan Partners.

Srini joined the Board in February 2016 and is Chair of George Health Enterprises.